Adjunct Minocyline in Treatment-resistant Depression
Status:
Completed
Trial end date:
2020-08-07
Target enrollment:
Participant gender:
Summary
This study examines the antidepressant efficacy of minocycline as an adjunct to an
antidepressant standard treatment (AD-ST), for patients with unipolar major depressive
disorder (MDD).